← FDA DRUG APPROVALS

FDA NDA · NDA016666

HIPPURAN I 131

Sponsor: MALLINCKRODT

APPLICATION
NDA016666
TYPE
NDA
ORIGINAL APPROVAL
1968-05-24
LATEST ACTION
1998-05-15
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

HIPPURAN I 131Discontinued
IODOHIPPURATE SODIUM I-131 0.25mCi/ML · INJECTABLE · INJECTION

Approval history

1998-05-15Manufacturing (CMC) · Supplement 15 · standardAP
1982-08-16Labeling · Supplement 12 · standardAP
1982-05-07Manufacturing (CMC) · Supplement 13 · standardAP
1978-04-07Manufacturing (CMC) · Supplement 10 · standardAP
1977-08-23Manufacturing (CMC) · Supplement 9 · standardAP
1977-07-27Manufacturing (CMC) · Supplement 8 · standardAP
1975-12-19Labeling · Supplement 6 · standardAP
1968-05-24Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →